Ionis Pharmaceuticals, Inc.
IONS
Helyezés a részvények között
#2579
Founded in 1989 and headquartered in Carlsbad, California, Ionis... Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adult patients; and WAYLIVRA, which addresses familial chylomicronemia syndrome and familial partial lipodystrophy. Ionis also maintains a robust pipeline, with several drug candidates currently in Phase 3 clinical trials. These include Eplontersen, a monthly self-administered subcutaneous injection designed for all forms of TTR amyloidosis; Olezarsen, intended for individuals with severe hypertriglyceridemia (SHTG); Donidalorsen, for patients suffering from hereditary angioedema; ION363, aimed at amyotrophic lateral sclerosis (ALS); Pelacarsen, developed for those with established cardiovascular disease and elevated lipoprotein(a); and Tofersen, which works by inhibiting the production of superoxide dismutase 1. Beyond these late-stage assets, the company is actively researching treatments for metabolic, infectious, renal, and ophthalmic diseases, as well as various types of cancer. The firm engages in significant collaborations, notably a strategic partnership with Biogen Inc. Additionally, it holds licensing and collaboration agreements with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc.
Részvényárfolyam
$43.84
Piaci kapitalizáció
$7.28B
Változás (1 nap)
-0.98%
Változás (1 év)
-38.69%
Ország
US
Kereskedés Ionis Pharmaceuticals, Inc. (IONS)
Kategória
Healthcare
Ionis Pharmaceuticals, Inc. (IONS) részvényárfolyamának története
Legmagasabb napi záróár: $43.86 ekkor: 2026-10-01
Legalacsonyabb napi záróár: $9.35 ekkor: 1991-05-01
Legalacsonyabb napi záróár: $9.35 ekkor: 1991-05-01
Ionis Pharmaceuticals, Inc. részvényárfolyamának története 1991 és 2026 között
Éves részvényárfolyam teljesítmény
| Év | Teljesítmény |
|---|---|
| 2026 (TTM) | -12.58% |
| 2025 | 118.12% |
| 2024 | -26.68% |
| 2023 | 30.56% |
| 2022 | 26.76% |
| 2021 | -42.71% |
| 2020 | -15.83% |
| 2019 | 18.26% |
| 2018 | 1.41% |
| 2017 | 8.18% |
| 2016 | -17.46% |
| 2015 | 0.07% |
| 2014 | 49.87% |
| 2013 | 299.73% |
| 2012 | 39.38% |
| 2011 | -29.73% |
| 2010 | -5.16% |
| 2009 | -14.30% |
| 2008 | -25.93% |
| 2007 | 41.58% |
| 2006 | 123.48% |
| 2005 | -11.84% |
| 2004 | 1.13% |
| 2003 | -15.98% |
| 2002 | -68.29% |
| 2001 | 125.06% |
| 2000 | -2.89% |
| 1999 | -13.03% |
| 1998 | -10.89% |
| 1997 | -28.15% |
| 1996 | 42.62% |
| 1995 | 203.93% |
| 1994 | -36.55% |
| 1993 | -34.00% |
| 1992 | -20.56% |
| 1991 | 0.00% |
Hasonló cégek vagy versenytársak részvényárai
| Vállalat | Részvényár | Változás 1év% | Ország |
|---|---|---|---|
| $535.97 | 25.69% |
US
|
|
| $190.72 | 610.32% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $889.32 | 9.23% |
NL
|
